How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches

Despite extensive research efforts, advanced gastric cancer still has a dismal prognosis with conventional treatment options. Immune checkpoint inhibitors have revolutionized the treatment landscape for many solid tumors. Amongst gastric cancer subtypes, tumors with microsatellite instability and Ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghidini, Michele, Petrillo, Angelica, Botticelli, Andrea, Trapani, Dario, Parisi, Alessandro, La Salvia, Anna, Sajjadi, Elham, Piciotti, Roberto, Fusco, Nicola, Khakoo, Shelize
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037391/
https://www.ncbi.nlm.nih.gov/pubmed/33915839
http://dx.doi.org/10.3390/jcm10071412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037391/
https://www.ncbi.nlm.nih.gov/pubmed/33915839
http://dx.doi.org/10.3390/jcm10071412

Ejemplares similares